A Case Report of Successful Treatment With Crizotinib to Overcome Resistance to Osimertinib in an EGFR Mutated Non–Small-Cell Lung Cancer Patient Harboring an Acquired MET Exon 14 Mutation
F. Pinquié, Alexis B. Cortot, Louise-Marie Chevalier, Alain Morel, Jérémy Sandrini, Camille Guguen, Benjamin Morvan, Olivier Molinier
Topics & Concepts
OsimertinibCrizotinibT790MMedicineLung cancerCancer researchOncologyLiquid biopsyAcquired resistanceInternal medicineCancerAdenocarcinomaEpidermal growth factor receptorErlotinibROS1Malignant pleural effusionLung Cancer Treatments and MutationsPI3K/AKT/mTOR signaling in cancerCholangiocarcinoma and Gallbladder Cancer Studies